lidoflazine has been researched along with Heart Failure in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lehmann, HU | 1 |
| Hochrein, H | 1 |
1 trial available for lidoflazine and Heart Failure
| Article | Year |
|---|---|
[Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
Topics: Aged; Arteriosclerosis; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Electrocardio | 1975 |